Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 12, Issue 5
|
pp. 4641–4659
Effects of the probiotic formulation SLAB51 in
in vitro
and
in vivo
Parkinson’s disease models
Back to article
Figure 7
(7 of 14)
−
100%
+
Figure 7.
(
A
) Procedural timeline with specific timepoints. (
B
) Body weight and behavioral tests in SHAM, SLAB51, 6-OHDA and 6-OHDA+SLAB51 animals. ** p< 0.005, *** p< 0.0005 vs Ctr; ++ p< 0.005, +++ p< 0.0005 vs 6-OHDA.
